Low disease activity state in rheumatoid arthritis: Concepts and derivation of minimal disease activity

George Wells, Maarten Boers, Peter Tugwell, Daniel Aletaha, Jennifer Anderson, Clair Bombardier, Peter Brooks, Maxime Dougados, Paul Emery, David Felson, Jaap Fransen, Dan Furst, Mieke Hazes, Kent Johnson, John Kirwan, Robert Landewé, Marissa Lassere, Kaleb Michaud, Beverley Shea, Maria Suarez-AlmazorAlan Silman, Lee Simon, Josef Smolen, Vibeke Strand, Desiree van der Heijde, Piet van Riel, Fred Wolfe

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

With recent advances in therapy, the proportion of patients achieving a satisfactory state of minimal disease activity (MDA) is becoming a more important measure with which to compare different treatment strategies. MDA is between high disease activity and remission and anyone in remission will also be in MDA. This paper summarizes the process of coming to a definition of minimal disease activity in rheumatoid arthritis. Two equivalent preliminary definitions of minimal disease activity for use as secondary outcome measures in clinical trials in RA are proposed: a core-set definition based on the WHO/ILAR core set and a DAS-based definition based on the DAS28.

Original languageEnglish (US)
Pages (from-to)S52-S59
JournalClinical and experimental rheumatology
Volume24
Issue number6 SUPPL. 43
StatePublished - Nov 1 2006

Fingerprint

Rheumatoid Arthritis
amsonic acid
Outcome Assessment (Health Care)
Clinical Trials
Therapeutics

Keywords

  • Low disease activity state
  • Minimal disease activity
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Wells, G., Boers, M., Tugwell, P., Aletaha, D., Anderson, J., Bombardier, C., ... Wolfe, F. (2006). Low disease activity state in rheumatoid arthritis: Concepts and derivation of minimal disease activity. Clinical and experimental rheumatology, 24(6 SUPPL. 43), S52-S59.

Low disease activity state in rheumatoid arthritis : Concepts and derivation of minimal disease activity. / Wells, George; Boers, Maarten; Tugwell, Peter; Aletaha, Daniel; Anderson, Jennifer; Bombardier, Clair; Brooks, Peter; Dougados, Maxime; Emery, Paul; Felson, David; Fransen, Jaap; Furst, Dan; Hazes, Mieke; Johnson, Kent; Kirwan, John; Landewé, Robert; Lassere, Marissa; Michaud, Kaleb; Shea, Beverley; Suarez-Almazor, Maria; Silman, Alan; Simon, Lee; Smolen, Josef; Strand, Vibeke; van der Heijde, Desiree; van Riel, Piet; Wolfe, Fred.

In: Clinical and experimental rheumatology, Vol. 24, No. 6 SUPPL. 43, 01.11.2006, p. S52-S59.

Research output: Contribution to journalReview article

Wells, G, Boers, M, Tugwell, P, Aletaha, D, Anderson, J, Bombardier, C, Brooks, P, Dougados, M, Emery, P, Felson, D, Fransen, J, Furst, D, Hazes, M, Johnson, K, Kirwan, J, Landewé, R, Lassere, M, Michaud, K, Shea, B, Suarez-Almazor, M, Silman, A, Simon, L, Smolen, J, Strand, V, van der Heijde, D, van Riel, P & Wolfe, F 2006, 'Low disease activity state in rheumatoid arthritis: Concepts and derivation of minimal disease activity', Clinical and experimental rheumatology, vol. 24, no. 6 SUPPL. 43, pp. S52-S59.
Wells G, Boers M, Tugwell P, Aletaha D, Anderson J, Bombardier C et al. Low disease activity state in rheumatoid arthritis: Concepts and derivation of minimal disease activity. Clinical and experimental rheumatology. 2006 Nov 1;24(6 SUPPL. 43):S52-S59.
Wells, George ; Boers, Maarten ; Tugwell, Peter ; Aletaha, Daniel ; Anderson, Jennifer ; Bombardier, Clair ; Brooks, Peter ; Dougados, Maxime ; Emery, Paul ; Felson, David ; Fransen, Jaap ; Furst, Dan ; Hazes, Mieke ; Johnson, Kent ; Kirwan, John ; Landewé, Robert ; Lassere, Marissa ; Michaud, Kaleb ; Shea, Beverley ; Suarez-Almazor, Maria ; Silman, Alan ; Simon, Lee ; Smolen, Josef ; Strand, Vibeke ; van der Heijde, Desiree ; van Riel, Piet ; Wolfe, Fred. / Low disease activity state in rheumatoid arthritis : Concepts and derivation of minimal disease activity. In: Clinical and experimental rheumatology. 2006 ; Vol. 24, No. 6 SUPPL. 43. pp. S52-S59.
@article{b1d6e48e354540e5a39fe2c0df0b8ab9,
title = "Low disease activity state in rheumatoid arthritis: Concepts and derivation of minimal disease activity",
abstract = "With recent advances in therapy, the proportion of patients achieving a satisfactory state of minimal disease activity (MDA) is becoming a more important measure with which to compare different treatment strategies. MDA is between high disease activity and remission and anyone in remission will also be in MDA. This paper summarizes the process of coming to a definition of minimal disease activity in rheumatoid arthritis. Two equivalent preliminary definitions of minimal disease activity for use as secondary outcome measures in clinical trials in RA are proposed: a core-set definition based on the WHO/ILAR core set and a DAS-based definition based on the DAS28.",
keywords = "Low disease activity state, Minimal disease activity, Rheumatoid arthritis",
author = "George Wells and Maarten Boers and Peter Tugwell and Daniel Aletaha and Jennifer Anderson and Clair Bombardier and Peter Brooks and Maxime Dougados and Paul Emery and David Felson and Jaap Fransen and Dan Furst and Mieke Hazes and Kent Johnson and John Kirwan and Robert Landew{\'e} and Marissa Lassere and Kaleb Michaud and Beverley Shea and Maria Suarez-Almazor and Alan Silman and Lee Simon and Josef Smolen and Vibeke Strand and {van der Heijde}, Desiree and {van Riel}, Piet and Fred Wolfe",
year = "2006",
month = "11",
day = "1",
language = "English (US)",
volume = "24",
pages = "S52--S59",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "6 SUPPL. 43",

}

TY - JOUR

T1 - Low disease activity state in rheumatoid arthritis

T2 - Concepts and derivation of minimal disease activity

AU - Wells, George

AU - Boers, Maarten

AU - Tugwell, Peter

AU - Aletaha, Daniel

AU - Anderson, Jennifer

AU - Bombardier, Clair

AU - Brooks, Peter

AU - Dougados, Maxime

AU - Emery, Paul

AU - Felson, David

AU - Fransen, Jaap

AU - Furst, Dan

AU - Hazes, Mieke

AU - Johnson, Kent

AU - Kirwan, John

AU - Landewé, Robert

AU - Lassere, Marissa

AU - Michaud, Kaleb

AU - Shea, Beverley

AU - Suarez-Almazor, Maria

AU - Silman, Alan

AU - Simon, Lee

AU - Smolen, Josef

AU - Strand, Vibeke

AU - van der Heijde, Desiree

AU - van Riel, Piet

AU - Wolfe, Fred

PY - 2006/11/1

Y1 - 2006/11/1

N2 - With recent advances in therapy, the proportion of patients achieving a satisfactory state of minimal disease activity (MDA) is becoming a more important measure with which to compare different treatment strategies. MDA is between high disease activity and remission and anyone in remission will also be in MDA. This paper summarizes the process of coming to a definition of minimal disease activity in rheumatoid arthritis. Two equivalent preliminary definitions of minimal disease activity for use as secondary outcome measures in clinical trials in RA are proposed: a core-set definition based on the WHO/ILAR core set and a DAS-based definition based on the DAS28.

AB - With recent advances in therapy, the proportion of patients achieving a satisfactory state of minimal disease activity (MDA) is becoming a more important measure with which to compare different treatment strategies. MDA is between high disease activity and remission and anyone in remission will also be in MDA. This paper summarizes the process of coming to a definition of minimal disease activity in rheumatoid arthritis. Two equivalent preliminary definitions of minimal disease activity for use as secondary outcome measures in clinical trials in RA are proposed: a core-set definition based on the WHO/ILAR core set and a DAS-based definition based on the DAS28.

KW - Low disease activity state

KW - Minimal disease activity

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=33750741119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750741119&partnerID=8YFLogxK

M3 - Review article

C2 - 17083764

AN - SCOPUS:33750741119

VL - 24

SP - S52-S59

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 6 SUPPL. 43

ER -